SARS-CoV-2および新たな変種に対する循環型RNAワクチン
Liang Qu1, Zongyi Yi2, Yong Shen2
1Biomedical Pioneering Innovation Center, Beijing Advanced Innovation Center for Genomics, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing 100871, China.
Cell
|April 23, 2022
まとめ
SARS-CoV-2のスパイクタンパク質を発現する新しい循環型RNA (circRNA) ワクチンは,動物モデルにおいて強力な保護性を示した. このcircRNAワクチンは,mRNAワクチンと比較して優れた抗原産生と免疫反応を示し,懸念される変種に対して広範な保護を提供した.
科学分野:
- ウイルス学
- 免疫学
- ワクチン開発
背景:
- 新興のSARS-CoV-2変種は,有効性を高め,より広範な保護を提供するワクチンを必要とする.
- 現在のワクチン戦略は,急速に変異するウイルス株に対処する上で課題に直面しています.
研究 の 目的:
- SARS-CoV-2に対する新しい循環型RNA (circRNA) ワクチンプラットフォームの開発および評価.
- 臨床前モデルのSARS-CoV-2変種に対するcircRNAワクチンの免疫性および保護効果を評価する.
主な方法:
- SARS-CoV-2のスパイクタンパク質のトリメリックRBDをコードするcircRNAワクチンが設計されました.
- ネズミとレサス・マカクの中和抗体とT細胞の反応を測定して,免疫性を評価した.
- ワクチンの有効性は,SARS-CoV-2 挑戦に対して評価され,改変された mRNA ワクチンと比較されました.
主要な成果:
- circRNAワクチンは強力な中和抗体とT細胞反応を誘発し,強力な保護を与えました.
- circRNAワクチンはmRNAワクチンよりも高い耐久性のある抗原生成を示した.
- circRNARBD-Deltaワクチンは,デルタとオミクロンの両方の変種に対して保護を提供し,効果的なブースターとして機能しました.
結論:
- 循環型RNAワクチンは,効果的なSARS-CoV-2ワクチンの開発のための有望なプラットフォームです.
- circRNAワクチンのプラットフォームは,抗原の生成と免疫応答の持続性に優れている.
- デルタ変種を標的としたcircRNAワクチンは,現在の懸念されるSARS-CoV-2変種に対して広範な有効性を示した.
関連する概念動画
Viruses with RNA Genomes
173
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
173
Size and Structure of Viral Genomes
182
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
182
Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
siRNA - Small Interfering RNAs
17.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K


